Mastrapasqua Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Mastrapasqua Asset Management's DGX Position: Q3 2023 in Review
Mastrapasqua Asset Management reduced its Quest Diagnostics (DGX) stake by 1.1% in Q3 2023, selling an estimated $24.6K and leaving 16,286 shares worth $1.98M. The position accounts for 0.23% of the portfolio, ranked #83.
Mastrapasqua Asset Management first reported a position in DGX in Q2 2020 and has held it in 14 quarters since. The position peaked at $3.36M in Q4 2021. 794 funds tracked by Wall St. Rank hold DGX as of Q3 2023.
- Mastrapasqua Asset Management held 16,286 shares of Quest Diagnostics worth $1.98M as of Q3 2023.
- Mastrapasqua Asset Management sold 185 Quest Diagnostics shares in Q3 2023, an estimated $24.6K.
- Quest Diagnostics made up 0.23% of Mastrapasqua Asset Management's portfolio in Q3 2023, its #83 holding.
- Mastrapasqua Asset Management first reported a position in Quest Diagnostics in Q2 2020 and has held it in 14 quarters since.
- Mastrapasqua Asset Management's Quest Diagnostics position peaked at $3.36M in Q4 2021.
- 794 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2023.
Based on Mastrapasqua Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.